SCHEMBL30439763

SCHEMBL30439763

NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ OPRD1 P41143 9/20 0.56
▸ OPRM1 P35372 5/20 0.56
▸ ACE P12821 1/20 0.46
▸ BDKRB2 P30411 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29531591 0.99 OPRD1 (0.57) OPRD1OPRM1ACEBDKRB2
SCHEMBL30439569 0.98 OPRD1 (0.57) OPRD1OPRM1ACEBDKRB2
SCHEMBL30116348 0.98 OPRD1 (0.57) OPRD1OPRM1ACEBDKRB2
SCHEMBL30116357 0.98 OPRD1 (0.56) OPRD1OPRM1ACE
SCHEMBL30503059 0.98 OPRD1 (0.56) OPRD1OPRM1ACE
SCHEMBL29392400 0.98 OPRD1 (0.56) OPRD1OPRM1ACE
SCHEMBL30439746 0.98 OPRD1 (0.56) OPRD1OPRM1ACE
SCHEMBL30116346 0.97 OPRD1 (0.59) OPRD1OPRM1ACE
SCHEMBL30116343 0.96 OPRD1 (0.59) OPRD1OPRM1ACE
SCHEMBL30533414 0.96 OPRD1 (0.59) OPRD1OPRM1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116419765-A GLP-1/GIP dual agonists, long acting conjugates thereof and pharmaceutical compositions comprising the same 韩美药品株式会社 2023-07-11 — — CN disclosed
CN-116390769-A Pharmaceutical composition for preventing or treating lupus-related diseases comprising glucagon/GLP-1/GIP triple agonist or long-acting conjugate thereof 韩美药品株式会社 2023-07-04 — — CN disclosed
CN-116322645-A Liquid formulations of long acting conjugates of GLP-2 韩美药品株式会社 2023-06-23 — — CN disclosed
Send feedback